CD4 and COVID-19: [43] In addition, as previously described for SARS-CoV infected patients [44], a decrease of CD4+ T and CD8+ T cells was also found in the context of COVID-19, and lymphopenia has been implicated as a risk factor for ARDS and mortality, suggesting that the adaptive immune system in the severe infection subgroup was less activated [45].